Sanofi Consumer Healthcare India Limited
SANOFICONR · Pharma · NSE
₹4,804
Current Market Price
Fair Value (DCF)
₹2,797
Margin of Safety
-41.8%
Updated 4h ago
YieldIQ Score
28/100
Piotroski F-Score
7/9
Economic Moat
Moderate
Confidence
41%
ROE
62.5%
Debt/Equity
0.00
WACC
11.0%
Market Cap
₹0.11 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
77.0%
Return on capital employed
EV / EBITDA
31.1×
Enterprise multiple
Debt / EBITDA
0.1×
Leverage vs earnings
Interest Coverage
161.2×
EBIT covers interest
Current Ratio
3.85×
Short-term liquidity
Asset Turnover
1.61×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹4,804
Bear case
₹1,728.03
MoS -178.0%
Base case
₹2,796.7
MoS -71.8%
Bull case
₹3,705.92
MoS -29.6%
Ratio Trends
SANOFICONR · last 3 annual periods
ROE
62.5%
ROCE
81.7%
Operating Margin
—
Debt / Equity
0.06×
PE
—
EV / EBITDA
—
Historical Financials
SANOFICONR · Annual, last 3 years· amounts in ₹Cr unless noted
| Metric | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|
| Revenue | ₹544 Cr | ₹171 Cr | ₹878 Cr | +27.0% |
| EBITDA | ₹221 Cr | ₹255 Cr | ₹334 Cr | +22.9% |
| EBIT | — | ₹63.2 Cr | — | +0.0% |
| PAT | ₹165 Cr | ₹44.3 Cr | ₹240 Cr | +20.7% |
| EPS (diluted) | — | ₹0.00 | — | — |
| CFO | ₹-0.4 Cr | ₹439 Cr | ₹175 Cr | — |
| CapEx | ₹-4.0 Cr | — | ₹-7.6 Cr | — |
| FCF | ₹-4.4 Cr | — | ₹167 Cr | — |
| Total Assets | ₹345 Cr | ₹431 Cr | ₹547 Cr | +25.8% |
| Total Debt | ₹0.0 Cr | ₹0.0 Cr | ₹24.8 Cr | — |
| Shareholders' Equity | ₹208 Cr | ₹273 Cr | ₹384 Cr | +36.0% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SANOFICONR vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SANOFI SANOFI | — | — | Pending | 43.6% | — |
| MARKSANS MARKSANS | — | — | Pending | 15.3% | — |
| RUBICON RUBICON | — | — | Pending | — | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for SANOFICONR in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Sanofi Consumer Healthcare India Limited (SANOFICONR.NS) trades at 4804.00 vs a model fair value of 2796.70, a gap of -41.8%. Piotroski F...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SANOFICONR →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SANOFICONR →
Compare
Head-to-head with peers
Compare SANOFICONR side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SANOFICONRNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.